XML 47 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Equity
12 Months Ended
Dec. 31, 2024
Text block [abstract]  
Equity
24.
EQUITY
 
  a.
Share capital
Ordinary shares
 
$                        $                       
    
December 31
 
    
2023
   
2024
 
Numbers of shares authorized (in thousands)
  
 
 5,500,000
 
 
 
 5,500,000
 
  
 
 
   
 
 
 
Numbers of shares reserved (in thousands)
    
Employee share options
  
 
400,000
 
 
 
400,000
 
  
 
 
   
 
 
 
Number of shares issued and fully paid (in thousands)
  
 
4,385,465
  
 
 
4,415,251
  
  
 
 
   
 
 
 
 
$                        $                        $                       
   
December 31
 
   
2023
   
2024
 
   
NT$
   
NT$
   
US$ (Note 4)
 
Share capital authorized
 
$
 55,000,000
 
 
$
 55,000,000
 
 
$
1,677,341
 
 
 
 
   
 
 
   
 
 
 
Share capital reserved
     
Employee share options
 
$
4,000,000
  
 
$
4,000,000
  
 
$
121,988
  
 
 
 
   
 
 
   
 
 
 
American Depositary Receipts
The Company’s ADS represents 2 ordinary shares of the Company. As of December 31, 2023 and 2024, 157,164 thousand ADSs were outstanding and represented approximately 314,328 thousand ordinary shares of the Company.
 
  b.
Capital surplus
 
$                        $                        $                       
   
December 31
 
   
2023
   
2024
 
   
NT$
   
NT$
   
US$ (Note 4)
 
May be used to offset a deficit,
distributed as cash dividends,
or transferred to share capital (1)
                 
Issuance of ordinary shares
 
$
15,737,752
 
 
$
16,519,296
 
 
$
503,791
 
Merger by share exchange
 
 
117,693,658
 
 
 
117,693,658
 
 
 
3,589,316
 
Difference between consideration and the carrying amount of the subsidiaries’ net assets during actual disposal or acquisition
 
 
3,240,987
 
 
 
3,240,987
 
 
 
98,841
 
Exercised employee share options
 
 
3,503,786
 
 
 
3,706,398
 
 
 
113,034
 
Treasury share transactions
 
 
679,791
 
 
 
1,059,253
 
 
 
32,304
 
Donation from shareholders
 
 
471,894
 
 
 
471,894
 
 
 
14,391
 
Expired share options
 
 
646,773
 
 
 
647,094
 
 
 
19,735
 
 
 
 
   
 
 
   
 
 
 
 
 
141,974,641
  
 
 
143,338,580
  
 
 
4,371,412
  
 
 
 
   
 
 
   
 
 
 
 
$                        $                        $                       
   
December 31
 
   
2023
   
2024
 
   
NT$
   
NT$
   
US$ (Note 4)
 
May be used to offset a deficit only
                 
Changes in percentage of ownership interest in subsidiaries (2)
 
$
208,310
 
 
$
40,151
 
 
$
1,224
 
Share of changes in capital surplus of associates accounted for using the equity method
 
 
21,584
 
 
 
26,029
 
 
 
794
 
Dividends that the claim period has elapsed and unclaimed by shareholders
 
 
6,130
 
 
 
6,198
 
 
 
189
 
Exercised disgorgement
 
 
326
  
 
 
326
  
 
 
10
  
 
 
 
   
 
 
   
 
 
 
 
 
236,350
 
 
 
72,704
 
 
 
2,217
 
 
 
 
   
 
 
   
 
 
 
May not be used for any purpose
                 
Employee share options
 
 
1,904,176
 
 
 
3,325,062
 
 
 
101,405
 
Employee restricted stock awards
 
 
(49,650
 
 
1,861,744
 
 
 
56,778
 
Others (3)
 
 
207,109
 
 
 
119,172
 
 
 
3,634
 
 
 
 
   
 
 
   
 
 
 
 
 
2,061,635
 
 
 
5,305,978
 
 
 
161,817
 
 
 
 
   
 
 
   
 
 
 
 
$
144,272,626
 
 
$
148,717,262
 
 
$
4,535,446
 
 
 
 
   
 
 
   
 
 
 
 
  1)
Such capital surplus may be used to offset a deficit; in addition, when the Company has no deficit, such capital surplus may be distributed as cash dividends or transferred to share capital (limited to a certain percentage of the Company’s capital surplus and once a year).
 
  2)
Such capital surplus arises from the effects of changes in ownership interests in subsidiaries resulting from equity transactions other than actual disposals or acquisitions, or from changes in capital surplus of subsidiaries accounted for using the equity method.
 
  3)
Such capital surplus represents the excess of the carrying amount of related accounts over the par value due to employee share options exercised and the Company has not completed registration formalities.
 
  c.
Retained earnings and dividend policy
The Articles of Incorporation of the Company (the “Articles”) provides that annual net income shall be distributed in the following order:
 
  1)
Replenishment of deficits;
 
  2)
10.0% as legal reserve;
 
  3)
Special reserve appropriated or reversed in accordance with laws or regulations set forth by the authorities concerned;
 
  4)
If annual net income remains, a proposal for the distribution of such amount together with a part or all of the accumulated undistributed profits from previous years shall be prepared by the board of directors and submit to the shareholders’ meeting for resolution. However, the distributable dividends may be paid in cash after a resolution has been adopted by a majority vote at a meeting of the board of directors attended by two-thirds of the total number of directors; and, in addition, a report of such distribution shall be submitted to the shareholders’ meeting.
 
For the policies on the distribution of employees’ compensation and remuneration of directors, refer to employees’ compensation and remuneration of directors in Note 25(g).
The Company is currently in the mature growth stage. To meet the capital needs for business development now and in the future and satisfy the shareholders’ demand for cash inflows, the Company shall use residual dividend policy to distribute dividends, of which the cash dividend is not lower than 30% of the total dividend distribution, with the remainder to be distributed in shares. A distribution plan is also to be made by the board of directors and submitted for resolution in the shareholders’ meeting.
Appropriation of earnings to legal reserve shall be made until the legal reserve equals the Company’s share capital. Legal reserve may be used to offset deficits. If the Company has no deficit and the legal reserve has exceeded 25% of the Company’s share capital, the excess may be transferred to capital or distributed in cash.
Items referred to under Rule No. 1090150022 issued by the Financial Supervisory Commission R.O.C. and in the directive titled “Questions and Answers for Special Reserves Appropriated Following Adoption of IFRS Accounting Standards” should be appropriated to or reversed from a special reserve by the Company.
The appropriation of earnings for 2022 and 2023 were as follows:
 
   
Appropriation of Earnings
   
Dividends Per Share
 
   
For Year 2022
   
For Year 2023
   
For Year 2022
   
For Year 2023
 
   
NT$
   
NT$
   
NT$
   
NT$
 
               
(in dollars)
   
(in dollars)
 
Legal reserve
  $ 6,001,564     $ 3,232,866      
 
 
 
   
 
 
     
Special reserve (reversed)
  $ (6,845,501   $ (167,613    
 
 
 
   
 
 
     
Cash dividends
  $ 38,482,083     $ 22,838,947       $  8.8       $  5.2  
 
 
 
   
 
 
     
The above 2022 and 2023 appropriations for cash dividends were resolved by the Company’s board of directors in March 2023 and 2024, respectively; the other proposed appropriations were resolved by the shareholders’ meeting in June 2023 and 2024, respectively.
 
  d.
Others equity items
 
  1)
Exchange differences on translating foreign operations
 
   
For the Year Ended December 31
 
   
2022
   
2023
   
2024
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Balance at January 1
 
$
(15,393,646
 
$
(5,529,388
 
$
(7,034,629
 
$
(214,536
Recognized for the year
       
Exchange differences arising on translating foreign operations
 
 
9,981,949
  
 
 
(1,488,920
 
 
12,101,346
 
 
 
369,056
 
 
   
For the Year Ended December 31
 
   
2022
   
2023
   
2024
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Share from associates and joint ventures accounted for using the equity method
 
$
(117,691
 
$
(16,321
 
$
(15,711
 
$
(479
 
 
 
   
 
 
   
 
 
   
 
 
 
Balance at December 31
 
$
 (5,529,388
 
$
(7,034,629
 
$
 5,051,006
 
 
$
154,041
 
 
 
 
   
 
 
   
 
 
   
 
 
 
 
  2)
Unrealized gain (loss) on financial assets at FVTOCI
 
   
$
                
   
$
                
   
$
                
   
$
                
 
 
 
For the Year Ended December 31
 
 
 
2022
 
 
2023
 
 
2024
 
 
 
NT$
 
 
NT$
 
 
NT$
 
 
US$ (Note 4)
 
         
Balance at January 1
 
$
4,190,361
 
 
$
1,275,505
 
 
$
3,549,648
 
 
$
108,254
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unrealized gain (loss) recognized for the year
 
     
 
     
 
     
 
     
Debt instruments
 
 
(16,746
 
 
(22,599
 
 
(14,830
 
 
(452
Equity instruments
 
 
(8,360
 
 
(77,496
 
 
(18,871
)
 
 
(576
)
Share from associates and joint ventures accounted for using the equity method
 
 
(2,928,173
 
 
2,447,656
 
 
 
155,784
 
 
 
4,751
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income for the year
 
 
(2,953,279
 
 
2,347,561
 
 
 
122,083
 
 
 
3,723
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cumulative unrealized loss of equity instruments transferred to retained earnings due to disposal
 
 
190,500
 
 
 
230,940
 
 
 
72,049
 
 
 
2,197
 
Cumulative unrealized gain transferred to retained earnings due to disposal of equity instruments in relation to associates and joint venture accounted for using the equity method
 
 
(152,077
 
 
(304,358
 
 
(13,221
 
 
(403
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Balance at December 31
 
$
 1,275,505
  
 
$
 3,549,648
  
 
$
 3,730,559
 
 
$
113,771
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  3)
Gain (loss) on hedging instruments – hedges of net investments of foreign operations
 
$                  $                  $                  $                 
   
For the Year Ended December 31
 
   
2022
   
2023
   
2024
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Balance at January 1
 
$
121,833
 
 
$
520,281
 
 
$
   277,441
  
 
$
8,461
  
Recognized for the year
       
Foreign currency risk - loans denominated in foreign currency
 
 
398,448
  
 
 
(242,840
 
 
438,262
 
 
 
13,366
 
 
 
 
   
 
 
   
 
 
   
 
 
 
Balance at December 31
 
$
    520,281
 
 
$
   277,441
  
 
$
715,703
 
 
$
 21,827
 
 
 
 
   
 
 
   
 
 
   
 
 
 
 
  4)
Unearned employee benefit
In August 2021 and June 2024, the shareholders’ meeting resolved to issue restricted stock awards to employees. Refer to Note 28 for the information.
 
$                  $                  $                  $                 
   
For the Year Ended December 31
 
   
2022
   
2023
   
2024
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Balance at January 1
 
$
(1,164,991
 
$
(432,847
 
$
-
 
 
$
-
 
Issuance of shares
 
 
-
 
 
 
-
 
 
 
(1,954,312
 
 
(59,600
)
Share-based payment expenses
 
 
    728,748
 
 
 
11,840
 
 
 
395,487
 
 
 
12,061
 
Valuation adjustments
 
 
3,396
 
 
 
   421,007
 
 
 
(72,432
 
 
(2,209
 
 
 
   
 
 
   
 
 
   
 
 
 
Balance at December 31
 
$
(432,847
 
$
-
 
 
$
(1,631,257
 
$
(49,748
 
 
 
   
 
 
   
 
 
   
 
 
 
 
  e.
Treasury shares
For the years ended December 31, 2023 and 2024, 72,941 thousand ordinary shares of the Company were held by its subsidiaries.
The Company’s shares held by its subsidiaries at each balance sheet date were as follows:
 
   
$
                
   
$
                
   
$
                
   
$
                
   
$
                
 
 
  
Shares

Held by
Subsidiaries
 
  
Carrying
Amount
 
  
Carrying
Amount
 
  
Fair Value
 
  
Fair Value
 
 
  
(in thousand
shares)
 
  
NT$
 
  
US$ (Note 4)
 
  
NT$
 
  
US$ (Note 4)
 
           
December 31, 2023
              
ASE
        67,452      $ 1,762,430     
 
   
 
   $  9,106,036     
 
   
 
ASE Test, Inc.
     5,489        196,677           741,067     
 
     
 
  
 
 
    
 
 
       
 
 
    
     72,941      $ 1,959,107         $ 9,847,103     
  
 
 
    
 
 
       
 
 
    
 
$
                
$
                
$
                
$
                
$
                
 
  
Shares

Held by
Subsidiaries
 
  
Carrying
Amount
 
  
Carrying
Amount
 
  
Fair Value
 
  
Fair Value
 
 
  
(in thousand
shares)
 
  
NT$
 
  
US$ (Note 4)
 
  
NT$
 
  
US$ (Note 4)
 
December 31, 2024
              
ASE
        67,452      $ 1,762,430      $ 53,749      $ 10,927,243      $ 333,249  
ASE Test, Inc.
     5,489        196,677        5,998        889,281        27,121  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
     72,941      $ 1,959,107      $ 59,747      $ 11,816,524      $ 360,370  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
The aforementioned fair value is classified as Level 1 fair value with quoted prices in an active market.
Under the Securities and Exchange Act in the R.O.C., the Company shall neither pledge treasury shares nor exercise shareholders’ rights on these shares, such as the rights to dividends and voting. The subsidiaries holding the aforementioned treasury shares are bestowed shareholders’ rights except the rights to participate in any share issuance for cash and voting.
 
  f.
Non-controlling interests
 
   
For the Year Ended December 31
 
   
2022
   
2023
   
2024
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Balance at January 1
 
$
 14,544,415
 
 
$
 18,608,124
 
 
$
 20,270,547
 
 
$
  618,193
 
Share of profit for the year
 
 
3,116,549
 
 
 
1,849,952
 
 
 
1,437,974
 
 
 
43,854
 
Other comprehensive income (loss) for the year
       
Exchange difference on translating foreign operations
 
 
344,780
 
 
 
(47,301
 
 
687,077
 
 
 
20,954
 
Unrealized gain (loss) on equity instruments at FVTOCI
 
 
(44,852
 
 
26,560
 
 
 
6,599
 
 
 
201
 
Gain (loss) from hedging
 
 
110,781
 
 
 
(69,189
 
 
124,336
 
 
 
3,792
 
Remeasurement on defined benefit plans
 
 
51,582
 
 
 
(15,876
 
 
3,270
 
 
 
100
 
Share in other comprehensive loss from associates accounted for using the equity method
 
 
(35,142
 
 
(7,514
 
 
(7,157
 
 
(218
Repurchase of outstanding shares by subsidiaries (Note 31)
 
 
(312,775
 
 
-
 
 
 
(270,291
 
 
(8,243
Disposal of subsidiary
 
 
-
 
 
 
(295,895
 
 
-
 
 
 
-
 
Non-controlling interest arising from capital increase of subsidiaries
 
 
-
 
 
 
427,913
 
 
 
177,487
 
 
 
5,413
 
 
   
For the Year Ended December 31
 
   
2022
   
2023
   
2024
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
The Group’s subscription for subsidiaries’ capital increase at a percentage different from its existing ownership (Note 31)
 
$
-
 
 
$
-
 
 
$
69,141
 
 
$
2,108
 
Cash dividends distributed to non-controlling interests
 
 
(575,089
 
 
(912,261
 
 
(593,390
 
 
(18,097
Non-controlling interest relating to outstanding vested employee share options granted by subsidiaries
 
 
315,871
 
 
 
293,740
 
 
 
238,183
 
 
 
7,264
 
Equity component of convertible bonds issued by subsidiaries
 
 
1,092,004
 
 
 
412,294
 
 
 
100,885
 
 
 
3,077
 
 
 
 
   
 
 
   
 
 
   
 
 
 
Balance at December 31
 
$
 18,608,124
 
 
$
 20,270,547
 
 
$
 22,244,661
 
 
$
  678,398